Valuation Ipsen

Stocks

Market Closed - Euronext Paris 09:25:00 14/08/2026 pm IST			5-day change	1st Jan Change
156.00 ^EUR	-0.95%		-3.47%	+31.09%

04/08	Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration	CI
03/08	Jefferies Downgrades Ipsen to Underperform, Boosts PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	12,790	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	30.92%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,573	10,549	9,754
Change	-	16.81%	12.22%	1.81%	2.28%	25.45%	-8.85%	-7.54%
P/E	10.4x	12.9x	14x	26.7x	22.4x	13x	13.7x	13.7x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.5x	2.12x	1.84x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-2.58x	-257.91x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.81x	2.8x	2.7x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.54x	2.31x	2.06x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.13x	6.12x	5.71x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7.02x	7.08x	6.56x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	8.97x	8.67x	7.94x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	11.1%	11.5%	12.6%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.98%	0.98%	1.06%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.03	11.39	11.38
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.8%	13.5%	14.5%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,553	4,571	4,743
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,888	1,723	1,709
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,647	1,491	1,488
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,002	960.3	951.3
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,217	-2,241	-3,036
Reference price ²	80.50	100.50	107.90	110.70	119.00	156.00	156.00	156.00
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IPSEN	12.97x	2.54x	6.13x	0.98%	1.48TCr
ELI LILLY AND COMPANY	33.76x	12.18x	24.85x	0.59%	1,05200Cr
JOHNSON & JOHNSON	28.96x	-	-	2.06%	63TCr
ABBVIE INC.	31.84x	7.42x	15.42x	2.75%	44TCr
ROCHE HOLDING AG	19.79x	4.7x	11.65x	2.81%	35TCr
NOVARTIS AG	21.42x	5.54x	13.77x	2.89%	29TCr
ASTRAZENECA PLC	19.89x	4.11x	11.68x	2.14%	24TCr
AMGEN INC.	26.26x	6.84x	12.14x	2.43%	22TCr
NOVO NORDISK A/S	13.32x	4.79x	9.96x	3.83%	20TCr
GILEAD SCIENCES, INC.	-42.28x	6.13x	23.96x	2.38%	17TCr
Average	16.59x	6.03x	14.39x	2.29%	36.1TCr
Weighted average by Cap.	24.13x	8.01x	17.67x	1.99%